Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical amitriptyline + ketamine + baclofen gel for post-mastectomy pain
IRCT20171030037093N13Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amitriptyline, ketamine and baclofen in Post-mastectomy pain syndrome (PMPS) (3 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Pain, Quality of life and 2 more. Started Jun 2019; status: completed.
02
Drugs
amitriptylineketaminebaclofen
03
Conditions
Post-mastectomy pain syndrome (PMPS)
Beyond the preview
Go deeper on IRCT20171030037093N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N13.